Home - Products - Apoptosis - Apoptosis - Bisindolylmaleimide VIII acetate

Bisindolylmaleimide VIII acetate

CAS No. 138516-31-1

Bisindolylmaleimide VIII acetate ( Ro 31-7549 acetate; Bis VIII acetate )

Catalog No. M23542 CAS No. 138516-31-1

Bisindolylmaleimide VIII acetate is a potent and selective PKC inhibitor (IC50: 158 nM for rat brain PKC).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 141 In Stock
10MG 224 In Stock
25MG 471 In Stock
50MG 683 In Stock
100MG 954 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bisindolylmaleimide VIII acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Bisindolylmaleimide VIII acetate is a potent and selective PKC inhibitor (IC50: 158 nM for rat brain PKC).
  • Description
    Bisindolylmaleimide VIII acetate is a potent and selective PKC inhibitor (IC50: 158 nM for rat brain PKC). It has IC50s of 53, 195, 163, 213, and 175 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, PKC-ε, respectively.
  • Synonyms
    Ro 31-7549 acetate; Bis VIII acetate
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis;PKC;PKCα;PKCβ1;PKCβ2;PKCγ;PKCε
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    138516-31-1
  • Formula Weight
    458.5
  • Molecular Formula
    C26H26N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C(C1=CN(CCCN)C2=C1C=CC=C2)=C3C4=CN(C)C5=C4C=CC=C5)NC3=O.CC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wilkinson SE, et al. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J. 1993 Sep 1;294 ( Pt 2):335-7.
molnova catalog
related products
  • TAS6417

    TAS6417 is an EGFR inhibitor and is an efficacious drug candidate for patients with NSCLC.

  • Pyrazoloacridine

    Pyrazoloacridine is a nucleic acid binding agent that inhibits the activity of topo I and II with an IC50 of 1.25 μM in K562 cells. Pyrazoloacridine shows anti-cancer activity.

  • Glycerol trioleate

    Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.